182 related articles for article (PubMed ID: 16495626)
1. Prophylactic valacyclovir to prevent outbreaks of primary herpes gladiatorum at a 28-day wrestling camp.
Anderson BJ
Jpn J Infect Dis; 2006 Feb; 59(1):6-9. PubMed ID: 16495626
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-Day Wrestling Camp: A 10-Year Review.
Anderson BJ; McGuire DP; Reed M; Foster M; Ortiz D
Clin J Sport Med; 2016 Jul; 26(4):272-8. PubMed ID: 26540599
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers.
Anderson BJ
Clin J Sport Med; 1999 Apr; 9(2):86-90. PubMed ID: 10442623
[TBL] [Abstract][Full Text] [Related]
4. Managing herpes gladiatorum outbreaks in competitive wrestling: the 2007 Minnesota experience.
Anderson BJ
Curr Sports Med Rep; 2008; 7(6):323-7. PubMed ID: 19005353
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum.
Anderson BJ
Med Sci Sports Exerc; 2003 Nov; 35(11):1809-14. PubMed ID: 14600542
[TBL] [Abstract][Full Text] [Related]
6. An outbreak of herpes gladiatorum at a high-school wrestling camp.
Belongia EA; Goodman JL; Holland EJ; Andres CW; Homann SR; Mahanti RL; Mizener MW; Erice A; Osterholm MT
N Engl J Med; 1991 Sep; 325(13):906-10. PubMed ID: 1652687
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir to expedite the clearance of recurrent herpes gladiatorum.
Anderson BJ
Clin J Sport Med; 2005 Sep; 15(5):364-6. PubMed ID: 16162997
[TBL] [Abstract][Full Text] [Related]
8. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
10. Herpes gladiatorum at a high school wrestling camp-United States.
Can Dis Wkly Rep; 1990 Mar; 16(10):46-8. PubMed ID: 2322948
[No Abstract] [Full Text] [Related]
11. Grappling with herpes: herpes gladiatorum.
Becker TM; Kodsi R; Bailey P; Lee F; Levandowski R; Nahmias AJ
Am J Sports Med; 1988; 16(6):665-9. PubMed ID: 2853577
[TBL] [Abstract][Full Text] [Related]
12. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
[TBL] [Abstract][Full Text] [Related]
13. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
14. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
16. Herpes gladiatorum at a high school wrestling camp--Minnesota.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1990 Feb; 39(5):69-71. PubMed ID: 2105440
[No Abstract] [Full Text] [Related]
17. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
18. Co-infection of herpes simplex virus (HSV) with human immunodeficiency virus (HIV) in women with reproductive tract infections (RTI).
Devi KM; Devi KhS; Singh NB; Singh NN; Singh ID
J Commun Dis; 2008 Sep; 40(3):193-7. PubMed ID: 19245157
[TBL] [Abstract][Full Text] [Related]
19. Detection of herpes simplex virus DNA in plasma of patients with primary but not with recurrent infection: implications for transfusion medicine?
Juhl D; Mosel C; Nawroth F; Funke AM; Dadgar SM; Hagenström H; Kirchner H; Hennig H
Transfus Med; 2010 Feb; 20(1):38-47. PubMed ID: 19708895
[TBL] [Abstract][Full Text] [Related]
20. Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: A randomized clinical trial of dosing regimens.
Gilbert S; McBurney E
Dermatol Surg; 2000 Jan; 26(1):50-4. PubMed ID: 10632686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
